Angela M. Kelle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Angela M. Kelle has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Constantine Mavroudis
Cleveland Clinic Foundation, Cleveland Clinic Lerner School of Medicine, Case Western Reserve University, Cleveland, Ohio
7 shared publicationsRobert D. Stewart
5 shared publicationsCarl L. Backer
4 shared publications- Carl Lewis Backer
Ann & Robert H. Lurie Children's Hospital of Chicago, formerly Children's Memorial Hospital, Chicago, IL, USA
4 shared publications Sunjay Kaushal
Division of Cardiovascular-Thoracic Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, Children's Memorial Hospital, Chicago, Ill
3 shared publications- Cynthia K. Rigsby
Department of Medical Imaging, Ann & Robert H Lurie Children’s Hospital of Chicago, Chicago, USA
2 shared publications
Latest Publications
- 27 February 2025
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 19 (6) , 817-819
Rapid growth of CT utilization compared to MRI and echocardiography in imaging for congenital heart disease: A multicenter analysis
- 27 February 2025
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 19 (6) , 817-819
Rapid growth of CT utilization compared to MRI and echocardiography in imaging for congenital heart disease: A multicenter analysis
- 13 May 2016
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 170 (8) , 2186-2190
Ebstein anomaly, left ventricular non‐compaction, and early onset heart failure associated with a de novo α‐tropomyosin gene mutation
Ebstein anomaly of the tricuspid valve (EA) can be associated with left ventricular non‐compaction (LVNC), a rare congenital cardiomyopathy. We report a 2 year‐old female with EA and severe tricuspid regurgitation, LVNC, pulmonary hypertension, and chronic biventricular systolic heart failure, who died during evaluation for cardiac transplantation. Gene panel testing revealed a heterozygous de novo missense mutation in TPM1, which encodes the cardiac sarcomeric thin filament protein α‐tropomyosin. The c.475G>A variant results in a p.Asp159Asn substitution, altering a highly conserved residue predicted to be damaging to protein structure and function. TPM1 is the second gene linked to EA with LVNC in humans, implicating overlap in the molecular basis of structural and myopathic heart disease.
- 13 May 2016
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 170 (8) , 2186-2190
Ebstein anomaly, left ventricular non‐compaction, and early onset heart failure associated with a de novo α‐tropomyosin gene mutation
Ebstein anomaly of the tricuspid valve (EA) can be associated with left ventricular non‐compaction (LVNC), a rare congenital cardiomyopathy. We report a 2 year‐old female with EA and severe tricuspid regurgitation, LVNC, pulmonary hypertension, and chronic biventricular systolic heart failure, who died during evaluation for cardiac transplantation. Gene panel testing revealed a heterozygous de novo missense mutation in TPM1, which encodes the cardiac sarcomeric thin filament protein α‐tropomyosin. The c.475G>A variant results in a p.Asp159Asn substitution, altering a highly conserved residue predicted to be damaging to protein structure and function. TPM1 is the second gene linked to EA with LVNC in humans, implicating overlap in the molecular basis of structural and myopathic heart disease.
- 1 December 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 116 (11) , 1762-1766
Familial Incidence of Cardiovascular Malformations in Hypoplastic Left Heart Syndrome
- 1 December 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 116 (11) , 1762-1766
Familial Incidence of Cardiovascular Malformations in Hypoplastic Left Heart Syndrome
- 1 May 2014
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 133 (5) , 943-949
Promoting Education, Mentorship, and Support for Pediatric Research
This Policy Statement was reaffirmed November 2023.: Pediatricians play a key role in advancing child health research to best attain and improve the physical, mental, and social health and well-being of all infants, children, adolescents, and young adults. Child health presents unique issues that require investigators who specialize in pediatric research. In addition, the scope of the pediatric research enterprise is transdisciplinary and includes the full spectrum of basic science, translational, community-based, health services, and child health policy research. Although most pediatricians do not directly engage in research, knowledge of research methodologies and approaches promotes critical evaluation of scientific literature, the practice of evidence-based medicine, and advocacy for evidence-based child health policy. This statement includes specific recommendations to promote further research education and support at all levels of pediatric training, from premedical to continuing medical education, as well as recommendations to increase support and mentorship for research activities. Pediatric research is crucial to the American Academy of Pediatrics’ goal of improving the health of all children. The American Academy of Pediatrics continues to promote and encourage efforts to facilitate the creation of new knowledge and ways to reduce barriers experienced by trainees, practitioners, and academic faculty pursuing research.
- 1 May 2014
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 133 (5) , 943-949
Promoting Education, Mentorship, and Support for Pediatric Research
This Policy Statement was reaffirmed November 2023.: Pediatricians play a key role in advancing child health research to best attain and improve the physical, mental, and social health and well-being of all infants, children, adolescents, and young adults. Child health presents unique issues that require investigators who specialize in pediatric research. In addition, the scope of the pediatric research enterprise is transdisciplinary and includes the full spectrum of basic science, translational, community-based, health services, and child health policy research. Although most pediatricians do not directly engage in research, knowledge of research methodologies and approaches promotes critical evaluation of scientific literature, the practice of evidence-based medicine, and advocacy for evidence-based child health policy. This statement includes specific recommendations to promote further research education and support at all levels of pediatric training, from premedical to continuing medical education, as well as recommendations to increase support and mentorship for research activities. Pediatric research is crucial to the American Academy of Pediatrics’ goal of improving the health of all children. The American Academy of Pediatrics continues to promote and encourage efforts to facilitate the creation of new knowledge and ways to reduce barriers experienced by trainees, practitioners, and academic faculty pursuing research.
- 1 June 2010
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 139 (6) , 1387-1394.e3
Total anomalous pulmonary venous connection: Results of surgical repair of 100 patients at a single institution
- 1 June 2010
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 139 (6) , 1387-1394.e3
Total anomalous pulmonary venous connection: Results of surgical repair of 100 patients at a single institution
- 1 October 2009
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 19 (S2) , 96-99
The Gerbode Defect: The Significance of a Left Ventricular to Right Atrial Shunt
Background: The so-called Gerbode ventriculo-atrial defect is a rare defect that permits shunting from the left ventricle to the right atrium. It takes 2 forms, either a deficiency of the atrioventricular membranous septum, or shunting initially through a ventricular septal defect, with atrial shunting occurring through a deficiency in the septal leaflet of the tricuspid valve. In this review, we describe the natural history and outcomes of surgical repair for the variant with shunting through a deficiency at the site of the atrioventricular membranous septum.Methods: From 1990 to 2008, we identified 6 patients from our departmental database who had undergone surgical closure of a congenital defect of the atrioventricular component of the membranous septum. Median age at repair was 1.6 years, with a range, from 0.4 to 19 years. All patients were symptomatic, with 3 having congestive cardiac failure, 2 failing to thrive, and 2 having intolerance to exercise. All had a dilated right atrium demonstrated by echocardiogram, with a mean preoperative gradient measured by echocardiogram to be 109 millimetres of mercury, with a range from 65 to 150 millimetres of mercury.Results: There was no operative or late mortality. The mean size of the defect was 6.2 ± 2.0 millimetres, with a range from 4 to 8 millimetres. All were closed by insertion of a patch. The mean period of cardiopulmonary bypass was 90.5 ± 11.3 minutes, the mean time of aortic cross-clamping 54.8 ± 6.9 minutes, and the mean length of stay in hospital 4.3 ± 1.0 days. No patient had a residual defect, and only trivial regurgitation of the tricuspid valve was evident by postoperative echocardiography. There were no complications or reoperations.Conclusion: The membranous ventriculo-atrial defect can be recognized echocardiographically on the basis of dilation of the right atrium in the setting of an unusually high Doppler echocardiogram gradient compared to the ventricular septal defect with shunting only at ventricular level. Since all patients in our series were symptomatic, we recommend surgical closure of all these defects.
- 1 October 2009
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 19 (S2) , 96-99
The Gerbode Defect: The Significance of a Left Ventricular to Right Atrial Shunt
Background: The so-called Gerbode ventriculo-atrial defect is a rare defect that permits shunting from the left ventricle to the right atrium. It takes 2 forms, either a deficiency of the atrioventricular membranous septum, or shunting initially through a ventricular septal defect, with atrial shunting occurring through a deficiency in the septal leaflet of the tricuspid valve. In this review, we describe the natural history and outcomes of surgical repair for the variant with shunting through a deficiency at the site of the atrioventricular membranous septum.Methods: From 1990 to 2008, we identified 6 patients from our departmental database who had undergone surgical closure of a congenital defect of the atrioventricular component of the membranous septum. Median age at repair was 1.6 years, with a range, from 0.4 to 19 years. All patients were symptomatic, with 3 having congestive cardiac failure, 2 failing to thrive, and 2 having intolerance to exercise. All had a dilated right atrium demonstrated by echocardiogram, with a mean preoperative gradient measured by echocardiogram to be 109 millimetres of mercury, with a range from 65 to 150 millimetres of mercury.Results: There was no operative or late mortality. The mean size of the defect was 6.2 ± 2.0 millimetres, with a range from 4 to 8 millimetres. All were closed by insertion of a patch. The mean period of cardiopulmonary bypass was 90.5 ± 11.3 minutes, the mean time of aortic cross-clamping 54.8 ± 6.9 minutes, and the mean length of stay in hospital 4.3 ± 1.0 days. No patient had a residual defect, and only trivial regurgitation of the tricuspid valve was evident by postoperative echocardiography. There were no complications or reoperations.Conclusion: The membranous ventriculo-atrial defect can be recognized echocardiographically on the basis of dilation of the right atrium in the setting of an unusually high Doppler echocardiogram gradient compared to the ventricular septal defect with shunting only at ventricular level. Since all patients in our series were symptomatic, we recommend surgical closure of all these defects.
- 1 August 2009
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 88 (2) , 624-631
Tracheal Reconstruction in Children With Unilateral Lung Agenesis or Severe Hypoplasia
- 1 August 2009
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 88 (2) , 624-631
Tracheal Reconstruction in Children With Unilateral Lung Agenesis or Severe Hypoplasia
- 1 December 2007
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 84 (6) , 2038-2046
Complete Atrioventricular Canal: Comparison of Modified Single-Patch Technique With Two-Patch Technique
- 1 December 2007
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 84 (6) , 2038-2046
Complete Atrioventricular Canal: Comparison of Modified Single-Patch Technique With Two-Patch Technique
- 1 December 2007
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 134 (6) , 1421-1428
Aprotinin is safe in pediatric patients undergoing cardiac surgery
- 1 December 2007
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 134 (6) , 1421-1428
Aprotinin is safe in pediatric patients undergoing cardiac surgery